In Philly, ‘tranq’ is leaving drug users with horrific wounds; unfamiliar optimism permeates Alzheimer's conference

The veterinary drug xylazinem, or "tranq," is now entrenched in Philly's illicit drug supply. Experts there are warning others to be on guard. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by       In Philadelphia, 'tranq' is leaving drug users with horrific wounds. Other communities are bracing for the same By Andrew Joseph Maria Fabrizio for STAT The veterinary drug xylazinem, or "tranq," is now entrenched in Philly's illicit drug supply. Experts there are warning others to be on guard. Read More STAT+: Alzheimer's researchers try out an unfamiliar sensation: optimism By Jonathan Wosen and Damian Garde Adobe For once, a new Alzheimer's medication appeared to work, but how well exactly? And can it lead to newer, better therapies? Read More 'The hospital never supported the midwives': As more birth centers open, their viability hinges on nearby hospitals By Theresa Gaffney Alissa Ambrose/STAT When a Massachusetts hospital announced plans to close a neighborhood birth center, local parents mounted a campaign to keep its doors open. Read More Sponsored Insight by Genentech How physicians and biotech are partnering to expand biomarker testing Personalized cancer care hinges on testing for the unique drivers of each person's cancer, but practical challenges keep many people from getting the tests they need. Learn how oncology care providers and biotech are working together to overcome biomarker testing barriers and expand access for patients everywhere. Image manipulation in science is suddenly in the news. But these cases are hardly rare By Adam Marcus and Ivan Oransky Hyacinth Empinado/STAT These cases aren't rare. A retraction for image manipulation happens about once every other day, according to a Retraction Watch database. Read More Opinion: Breakthrough Therapies Act: Good idea, wrong solution By Arthur L. Caplan and Kenneth I. Moch Adobe The Breakthrough Therapies Act is the wrong way to expand access for therapeutic purposes to Schedule I substances like psilocybin and LSD. Read More STAT+: An Anavex study spin job sullies an otherwise spectacular Alzheimer's conference By Adam Feuerstein Molly Ferguson/STAT The company’s presentation was a textbook demonstration of the deep bag of tricks that can be deployed to spin results. Read More Opinion: Congress: Close the gap between funding for nutrition research and the toll diet-related disease takes on Americans By Bill Frist and Dariush Mozaffarian Adobe Funding for nutrition research has been flat even as diet-related conditions have become the leading cause of death and disability in the U.S. Read More Friday, December 2, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser